Overview
Okeiro is an AI HealthTech company based in Paris, France, founded in 2023. The company has developed an AI-powered platform designed to support clinical decision-making in chronic disease and transplant care settings.
The platform addresses the clinical challenge of identifying high-risk patients and determining appropriate treatment pathways. By providing early detection capabilities and personalised treatment recommendations, Okeiro aims to assist clinicians in making timely, informed decisions for patients requiring ongoing or post-transplant management.
Activities and products
Okeiro's primary offering is an AI-powered platform that delivers early detection and personalised treatment pathways for high-risk patients in chronic disease and transplant care contexts. The platform is designed to support clinicians by providing data-driven insights to inform clinical decision-making and patient management strategies.
Stage and funding
Okeiro is at seed stage and has raised €10 million in funding. The company's investors and detailed funding round information are not currently verified.
Company details
- Legal name
- Okeiro
- Website
- okeiro.com
- Headquarters
- Paris, France
- Founded
- 2023
- Sector
- AI HealthTech
- Funding stage
- Seed